Impact of Silicon-based Formulations on Wound Healing of Laser-induced Microscopic Skin Lesions (SPASM11)
Wound Healing
About this trial
This is an interventional other trial for Wound Healing
Eligibility Criteria
Inclusion Criteria: Healthy adult volunteers age ≥18 years to 50 years Subjects must be willing and able to participate as required by the protocol. Subjects must be willing and able to provide written informed consent. Exclusion Criteria: Evidence of any relevant skin or systemic disease (for example diabetes mellitus, cardiovascular disease, hypertension, chronic or acute skin disease) possibly affecting the wound healing of the test site. Any skin alteration (for example tattoo or scar) on the test site. Test sites with terminal hairs Pregnancy or breastfeeding. History of hypertrophic scars or keloid formation or a similar abnormal wound healing. Intake of any drug which in the evaluation of the investigator may interfere with the interpretation of trial results or are known to cause clinically relevant interferences. Body Mass Index (BMI) > 36 kg/m². Have any other condition (including drug abuse, alcohol abuse, or psychiatric disorder) that, in the opinion of the investigator, precludes the patient from following and completing the protocol.
Sites / Locations
- Hôpitaux universitaires de Genève
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Control
Formulation 1
Formulation 2